Abstract
Recent studies have established that excessive nitric oxide (NO) is produced during the course of both the human and the MRL/lpr model of systemic lupus erythematosus (SLE) (1–6). Although the inhibition of NO synthesis improves outcome in the MRL/lpr mice, the role of NO in the pathogenesis of SLE is as yet undetermined. The biology of NO, produced by constitutive or induced enzymes in virtually all tissues, is likely to exert complex actions on both immunologic and inflammatory processes. This chapter reviews the data that indicate that NO might play an important role in SLE. There is an emphasis on the biological reactivity of NO as well as its effects on cells of inflammation and immunity. An understanding of the pleiotropic effects of NO could advance our understanding of the pathogenesis of SLE and possibly lead to novel therapeutic strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weinberg, J. B., Granger, D. L., Pisetsky, D. S., Seldin, M. F., Misukonis, M. A., Mason, S. N., Pippen, A. M., Ruiz, P., Wood, E. R., and Gilkeson, G. S. (1994) The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J. Exp. Med. 179, 651–660.
Oates, J. C., Ruiz, P., Alexander, A., Pippen, A. M., and Gilkeson, G. S. (1997) Effect of late modulation of nitric oxide production on murine lupus. Clin. Immunol. Immunopathol. 83, 86–92.
Gilkeson, G., Seldin, M., Mudgett, J., and Weinberg, B. ( 1996 Abstract) MRL-lpr mice lacking iNOS develop significant nephritis and arthritis. J. Exp. Med. 186, 365–373 (abstract).
Oates, J. C., Gilkeson, G. S. (1997) Increased apoptosis of MRL/lpr mice is secondary to elevated nitric oxide production. Arthritis Rheum. 40, 9 (Suppl): S250.
Belmont, H. M., Levartovsky, D., Goel, A., Amin, A., Giorno, R., Rediske, J., Skovron, M. L., and Abramson, S. B. (1997) Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum. 40, 1810–1816.
Gilkeson, G., Cannon, C., Goldman, D., and Petri, M. (1996) Correlation of a serum measure of nitric oxide production with lupus disease activity measures (abstract). Arthritis Rheum. 39 (Suppl. 9), S251.
Furchgott, R. F., and Zawadzki, J. V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373–376.
Palmer, R. M., Ferrige, A. G., and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524–526.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84, 9265–9269.
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., and Snyder, S. H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714–718.
Xie, Q. W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225–228.
Lamas, S., Mardsden, P. A., Li, G. K., Tempst, P., and Michel, T. (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 89, 6348–6352.
Janssens, S. P., Shimouchi, A., Quertermous, T., Bloch, D. B., and Bloch, K. D. (1992) Cloning and expression of a cDNA encoding human endothelium derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267, 14,519–14, 522.
Lyons, C. R., Orloff, G. J., and Cunningham, J. M. (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267, 6370–6374.
Nathan, C. (1997) Perspectives series: nitric oxide and nitric oxide synthases. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100, 2417–2423.
Gorbunov, N., and Esposito, E. (1993) Nitric oxide as a mediator of inflammation. Int. J. Immunopathol. Pharmacol. 6, 67–75.
Marletta, M. A. (1994) Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78, 927–930.
Iyengar, R., Stuehr, D. J., Marietta, M. A. (1978) Macrophage-synthesis of nitrite, nitrate, and N-nitrosamines• precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84, 6369–6373.
Stamler, J. S., Singel, D. J., and Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898–1902.
Kaur, H., and Halliwell, B. (1994) Evidence for nitric oxide-mediated oxidative damage in chronic inflammation: nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350, 9–12.
Gorczyca, W., et al. (1993) Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7, 659–670.
Hibbs, J. B., Taintor, R. R., Vavrin, Z., and Rachlin, E. M. (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87–94.
Hibbs, J. B., Taintor, R. R., and Vavrin, Z. (1984) Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem. Biophys. Res. Commun. 123, 716.
Drapier, J. C., and Hibbs, J. B. (1986) Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Clin. Invest. 78, 790–797.
Stadler, J., Billiar, T. R., Curran, R. D., Stuehr, D. J., Ochoa, J. B., and Simmons, R. L. (1991) Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260, C910.
Clancy, R. M., and Abramson, S. B. (1992) Novel synthesis of S-nitrosoglutathione and degradation by human neutrophils. Analyt. Biochem. 204, 365–371.
Myers, P. R., Minor, R. L. Jr., Guerra, R. Jr., Bates, J. N., and Harrison, D. G. (1990) Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345, 161–163.
Gow, A., Buerk, D. G., and Ischiropoulos, H. (1997) A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J. Biol. Chem. 272, 2841–2845.
Chevalier, X., Caludepierre, P., Groult, N., Zardi, L., and Hornebeck, W. (1996) Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. J. Rheumatol. 23, 1022–1030.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., and Loscalzo, J. (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89, 7674–7677.
Clancy, R. M., Levartovsky, D., Leszczynska-Piziak, J., Yegudin, J., and Abramson, S. B. (1994) Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA 91, 3680–3684.
Jia, L., Bonaventura, C., Bonaventura, J., and Stamler, J. S. (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380, 221–226.
Brune, B., and Lapetina, E. G. (1989) Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem. 264, 8455–8458.
McDonald, L. J., and Moss, J. (1993) The nitric oxide-enhanced modification of GAPDH by NAD is a covalent bond between NAD and a thiol residue in GAPDH. Proc. Natl. Acad. Sci. USA 90, 6238–6242.
Clancy, R. M., Leszczynska-Piziak, J., and Abramson, S. B. (1993) Nitric oxide stimulates the ADP-ribosylation of actin in human neutrophils. Biochem. Biophys. Res. Commun. 191, 847–852.
Clancy, R., Leszczynska, J., Amin, A., Levartovsky, D., and Abramson, S. B. (1995) Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J. Leukoc. Biol. 58, 196–202.
Frenkel, S. R., Clancy, R. M., Ricci, J. L., Di Cesare, P. E., Rediske, J. J., and Abramson, S. B. (1996) Effects of nitric oxide on chondrocyte migration, adhesion and cytoskeletal assembly. Arthritis Rheum. 39, 1905–1912.
Clancy, R., Rediske, J., Tang, X., Nijher, N., Frenkel, S., Philips, M., and Abramson, S. B. (1997) Outside-in signaling in the chondrocyte: nitric oxide disrupts fibronectin-induced assembly of a subplasmalemmal actin/Rho A/focal adhesion kinase signaling complex. J. Clin. Invest. 100, 1789–1796.
Zhang, J., Dawson, V. L., Dawson, T. M., and Snyder, S. H. (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263, 687–689.
Schraufstatter, I. U., Hinshaw, D. B., Hyslop, P. A., Spragg, R. G., and Cochrane, C. G. (1986) Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77, 1312–1320.
Radons, J., Heller, B., Burkle, A., Hartmann, B., Rodriguez, M. L., Kroncke, K. D., Burkart, V., and Kolb, H. (1994) Nitric oxide toxicity in islet cells involves poly (ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem. Biophys. Res. Commun. 199, 1270–1277.
Gilkeson, G., Mudgett, J. S., Seldin, M. F., Ruiz, P., Alexander, A. A., Misukonis, M. A., Pisetsky, D. S., and Weinberg, J. B. (1997) Clinical and serologic manifestations of autoimmune disease in MRL-1pr/lpr mice lacking nitric oxide synthase type 2. J. Exp. Med. 186, 365–373.
Belmont, H. M., Buyon, J., Giorno, R., and Abramson, S. (1994) Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematous: the shwartzman phenomenon revisited. Arthritis Rheum. 37, 376–383.
Belmont, H. M., Abramson, S. B., and Lie, J. T. (1996) Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 39, 9–22.
Hutcheson, A. R., Whittle, B. J. R., and Boughton-Smith, N. K. (1990) Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br. J. Pharmacol. 1282, 7889–7891.
Petros, A., Bennett, D., and Valiance, P. (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338, 1557–1558.
Fang, F. C. (1997) Perspective series: First host/pathogen interactions. Mechanisms of nitric oxide related antimicrobial activity. J. Clin. Invest. 99, 2818–2825.
Middleton, S. J., Shorthouse, M., and Hunter, J. O. (1993) Increased nitric oxide synthesis in ulcerative colitis. Lancet 341, 465–466.
Kolb-Bachofen, V., Fehsel, K., Michel, G., and Ruzicka, T. (1994) Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 344, 139.
McCartney-Francis, N., Allen, J. B., Mizel, D. E., Albina, J. E., Xie, Q. W., Nathan, C. F., and Wahl, S. M. (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178, 749–754.
Amin, A. R., Di Cesare, P. E., Vyas, P., Attur, M., Tzeng, E., Billiar, T. R., Stuchin, S. A., and Abramson, S. B. (1995) The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J. Exp. Med. 182, 2097.
St. Clair, E. W., Wilkinson, W. E„ Lang, T., Sanders, L., Misukonis, M. A., Gilkeson, G. S., Pisetsky, D. S., Granger, D. L., and Weinberg, J. B. (1996) Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med. 184, 1173–1178.
Parkinson, J. F., Mitrovic, B., and Merrill, J. E. (1997) The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75, 174–186.
Kolb, H., and Kolb-Bachofen, V. (1992) Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia 35, 796.
Weyand, C. M., Wagner, A. D., Bjornsson, J., and Goronzy, J. J. (1996) Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98, 1642–1649.
Kontinnen, Y. T., Platts, L. A., Tuominen, S., Eklund, K. K., Santavirta, N., Tornwall, J., Sorsa, T., Hukkanen, M., and Polak, J. M. (1997) Role of nitric oxide in Sjogren’s syndrome. Arthritis Rheum. 40, 875–883.
Shimakoa, M., Lida, T., Ohara, A., Taenaka, N., Mashimo, T., Honda, T., and Yoshiya, T. (1995) NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209, 519–525.
Kitajima, I., Kawahara, K., Nakajima, T., Soejima, Y., Matsuyama, T., and Maruyama, I. (1994) Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204, 244–251.
Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent mechanisms. Cancer Res. 54, 2462–2467.
Ankarcrona, M., Dypbukt, J. M., Brune, B., and Nicotera, P. (1994) Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancratic RINm5F cells. Exp. Cell. Res. 213, 172–177.
Fehsel, K., Kroncke, K. D., Meyer, K. L., Huber, H., Wahn, V., and Kolb-Bachofen, V. (1995) Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155, 2858–2865.
Albina, J. E., Cui, S., Mateo, R. B., Reichner, J. S. (1997) Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150, 5080–5085.
Melkova, Z., Lee, S. B., Rodriguez, D., and Esteban, M. (1997) Bc1–2 prevents nitric oxide-mediated apoptosis and poly(ADP-ribose) polymerase cleavage. FEBS Lett. 403, 273–278.
Farrell, A. J., and Blake, D. R. (1996) Nitric oxide. Ann. Rheum. Dis. 55, 7–20.
Kim, Y-M., Talanian, R. V., and Billiar, R. (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272, 31,138–31, 148.
Mariani, S. M., Matiba, B., Armandola, A., and Krammer, P. H. (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J. Immunol. 24, 3119–3123.
Van Houten, N., and Budd, R. C. (1992) Accelerated programmed cell death of MRLlpr/lpr T lymphocytes. J. Immunol. 149, 2513–2517.
Efron, D. T., Kirk, S. J., Regan, M. C., Wasserkrug, H., and Barbul, A. (1991) Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery 110, 327–334.
Mills, C. D. (1991) Molecular basis of “suppressor” macrophages: arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146, 2713.
Merryman, P. F., Clancy, R. M., He, X. H., and Abramson, S. B. (1993) Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum. 36, 1414–1422.
Chang, R. H., Feng, M. H., Liu, W. H., and Lai, M. Z. (1997) Nitric oxide increased interleukin-4 expression T lymphocytes. Immunology 90, 364–369.
Bauer, H., Jung, T., Tsikas, D., Stichtenoth, D. O., Frolich, J. C., and Neumann, C. (1997) Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 90, 205–211.
Stadler, J., Stefanovic-Racic, M., Billiar, T. R., Curran, R. D., McIntyre, L., Georgescu, H. I., Simmons, R. L., and Evans, C.H. (1991) Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147, 3915–3920.
Beasley, D., Schaneartz, J. H., Brenner, B. M. (1991) Interleukin-1 induces prolonged Larginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87, 602–608.
Clancy, R. M., and Abramson, S. B. (1995) Nitric oxide: a novel mediator of inflammation. Soc. Exp. Biol. Med. 210, 93–101.
Billiar, T. R. (1995) Nitric oxide: novel biology with clinical relevance. Ann. Surg. 221, 339–349.
Mauel, J., and Corradin, S. B. (1991) Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide. J. Immunol. 146, 279–285.
Kubes, P. M., Suzuki, M., and Granger, D. N. (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88, 4651–4655.
Mulligan, M. S., Hevel, J. M., Marletta, M. A., and Ward, P. A. (1991) Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA 88, 6338–6342.
Oruvic, A., Hearn, S., and Lala, P. K. (1997) The role of nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 in mice. Lab. Invest. 76, 53–65.
Bouchier-Hayes, D., Abdih, H., Kelly, C. J., Barry, M., Redmond, H. P., Burke, P., Tanner, A., and Bouchier-Hayes, D. J. (1997) Nitric oxide attenuates interleukin 2-induced lung injury. Br. J. Surg, 84, 540–542.
Masini, E., Pistelli, A., Gambassi, F., Di Bello, M. G., and Mannaioni, P. F. (1996) The role of nitric oxide in anaphylactic reaction of isolated guinea pig hearts and mast cells, in Nitric Oxide: Brain and Immune System. ( Moncada, S., and Nishko, G., eds.), Portland Press, London, p. 277.
Roissaint, R., Falke, K. J., Lopez, F., Slama, K., Pison, U., and Zapol, W. M. (1993) Inhaled oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328, 399–405.
Bloomfield, G. L., Halloway, S., Ridings, P. C., Fisher, B. J., Blocher, C. R., Sholley, M., Bunch, T., Sugerman, H. J., and Fowler, A. A. (1997) Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit. Care Med. 25, 584–593.
Cooke, J. P., and Tsao, P. S. (1993) Cytoprotective effects of nitric oxide. Circulation 88, 2451–2455.
Lefer, A. M. (1992) Cytoprotective actions of nitric oxide donors in ischemia-reperfusion injury, in The Biology of Nitric Oxide. (Moncada, S., Marietta, M. A., Higgs. E. A., eds.), Portland Press, London, p. 55.
Murohara, T., Parkinson, S. J., Waldman, S. A., Lefer, A. M. (1995) Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: role of protein kinase C. Arterioscl. Thromb. Vasc. Biol. 15, 2068–2075.
Clancy, R. M., Leszczynska-Piziak, J., and Abramson, S. B. (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90, 1116–1121.
Spronk, P. E., Bootsma, H., Huitema, M. G., et al. (1994) Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE): a long term prospective study. Clin. Exp. Immunol. 97, 439–444.
McMurray, R. W. (1996) Adhesion molecules in autoimmune disease. Semin Arthritis Rheum. 25, 215–233.
Bullard, D. C., King, P. D., Hicks, M. J., Dupont, B., Beaudet, A. L., and Elkon, K. B. (1997) Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-FaslPr mice from early lethality J. Immunol. 15, 2058–2067.
Pall, A. A., and Savage, C. O. S. (1994) Mechanisms of endothelial cell injury in vasculitis. Springer Semin. Immunopathol. 16, 23–37.
Kilgore, K. S., Shen, J. P., Miller, B. F., Ward, P. A., and Warren, J. S. (1995) Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155, 1434–1443.
Saadi, S., Holzknecht, R. A., Patte, C. P., Stern, D. M., and Platt, J. L. (1995) Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182, 1807–1814.
Lozada, C., Levin, R. I., Huie, M., Hirschhorn, R., Naime, D., Whitlow, M., Recht, P. A., Golden, B., and Cronstein, B. N. (1995) Identification of Clq as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules. Proc. Natl. Acad. Sci. USA 92, 8378–8382.
Neng Lai, L. K., Leung, J. C., Bil Lai, K., Li, P. K., and Lai, C. K. (1996) Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from human endothelial cells. J. Pathol. 178, 451–458.
Lai, K. N., Leung, J. C., Lai, K. B., Wong, K. C., and Lai, C. K. (1996) Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 81, 229–238.
Nogare, D. (1991) Septic shock. Am. J. Med. 302, 50–65.
Bone, R. C. (1993) Why new definitions of sepsis and organ failure are needed. Am. J. Med. 95, 348–354.
Waage, A., Brandtzaeg, P., Espevik, T., and Halstensen, A. (1991) Current understanding of the pathogenesis of gram-negative shock. Infect. Dis. Clin. North Am. 5, 781–789.
Walsh, C. J., Carey, P. D., Bechard, D. E., Fowler, A. A., and Sugerman, H. J. (1991) AntiCD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis. Surgery 110, 205–211.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Belmont, H.M., Amin, A.R., Abramson, S.B. (1999). Nitric Oxide in Systemic Lupus Erythematosus. In: Kammer, G.M., Tsokos, G.C. (eds) Lupus. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-703-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-703-1_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5686-9
Online ISBN: 978-1-59259-703-1
eBook Packages: Springer Book Archive